Physician profile
Mark A Thompson
NPI 1538136361
$663.29
in general payments reported to CMS, 2019-2025
9 companies · $41.05 in 2025
The $41.05 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2022: $82.30 · 2023: $281 · 2024: $75.12 · 2025: $41.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $257.42 | 2022-2024 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2019 | |
| Medtronic, INC. | $109.74 | 2023 | Signia |
| W. L. Gore & Associates, INC. | $71.62 | 2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Portola Pharmaceuticals, LLC | $27.64 | 2019 | |
| Gilead Sciences, INC. | $22.03 | 2025 | |
| Ethicon US, LLC | $19.02 | 2025 | Echelon Circular |
| Bard Peripheral Vascular, INC. | $18.63 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.